• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB1900344 Tremelimumab tremelimumab Injection Biological Products Supplementary Application 2019-12-18 Medimmune LLC;Boehringer Ingelheim Pharma Gmbh & Co KG In Review 2019-12-17 view
JXSS2500016 Tremelimumab注射液 tremelimumab Injection Biological Products(3.1) Import Drug Application 2025-02-21 Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd view
JXSS2500015 Tremelimumab注射液 tremelimumab Injection Biological Products(3.1) Import Drug Application 2025-02-21 Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd view
JXSS2400099 Tremelimumab注射液 tremelimumab Injection Biological Products(3.1) Import Drug Application 2024-10-18 Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd view
JXSS2400097 Tremelimumab注射液 tremelimumab Injection Biological Products(3.1) Import Drug Application 2024-10-18 Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd view
JXSL2500078 Tremelimumab注射液 tremelimumab Injection Biological Products(2.2) Import Drug Application 2025-05-20 Medimmune LLC;Astrazeneca Investment (China) Co Ltd view
JXSL2500005 Tremelimumab tremelimumab Injection Biological Products(2.2) Import Drug Application 2025-01-09 Medimmune LLC;AstraZeneca Global R&D (China) Co Ltd view
JXSL2500004 Tremelimumab tremelimumab Injection Biological Products(2.2) Import Drug Application 2025-01-09 Medimmune LLC;AstraZeneca Global R&D (China) Co Ltd view
JXSL2400249 Tremelimumab注射液 tremelimumab Injection Biological Products(2.2) Import Drug Application 2024-12-25 Medimmune LLC;Astrazeneca Investment (China) Co Ltd view
JXSL2200045 Tremelimumab tremelimumab Injection Biological Products(1) Import Drug Application 2022-04-12 Medimmune LLC;AstraZeneca Global R&D (China) Co Ltd view
JXSL2200021 Tremelimumab tremelimumab Injection Biological Products(1) Import Drug Application 2022-03-04 Medimmune LLC;AstraZeneca Global R&D (China) Co Ltd view
JXSL1800076 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2019-01-09 Medimmune LLC In Review 2019-01-08 view
JXSL1800046 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2018-11-09 Medimmune LLC In Review 2018-11-08 view
JXSL1700054 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2017-09-13 MedImmune LLC Medimmune LLC Certificate Issued 2018-01-23 view
JXSL1700027 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2017-05-31 MedImmune LLC Medimmune LLC Certificate Issued 2017-10-27 view
JXSL1700013 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2017-03-27 MedImmune LLC Medimmune LLC Certificate Issued 2017-08-22 view
JXSL1600014 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2016-03-14 MedImmune LLC Medimmune LLC Certificate Issued 2016-11-09 view
JXSL1500071 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2015-12-11 MedImmune LLC Medimmune LLC Certificate Issued 2016-11-08 view
JXSL1500067 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2015-11-26 MedImmune LLC Medimmune LLC Certificate Issued 2017-01-03 view
JXSL1500065 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2015-11-26 MedImmune LLC Medimmune LLC Certificate Issued 2016-08-25 view